Login to Your Account

Regulatory NEWS

HONG KONG – Reforms to China's drug approval process are gradually changing the industry, but the reforms are not making things easier for multinational drugmakers looking to launch new medicines in the country.

The nomination of Seema Verma to the administrator of CMS came with many of the typical tough questions and a concomitant reluctance to answer directly at times.

KARACHI, Pakistan – Facing a chronic shortage of regulations, the biopharmaceutical industry in Pakistan is struggling to get traction despite widespread need and huge market potential.

More Regulatory Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: